http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0112791-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0096
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2001-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c4eafc3a95600d8f00759593293eccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_854cf9eebe3a2622efada66c74f9da88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15168343f967357d7f2d2234f0e9877e
publicationDate 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0112791-A
titleOfInvention 16alpha-substituted steroidal compound, use thereof, treatment methods for selective activation of alpha subtype estrogen receptors, and for hormone replacement therapy or contraception, and, pharmaceutical composition
abstract "ALPHA-SUBSTITUTED STEROID COMPOUND, USE OF THE SAME, TREATMENT METHODS FOR SELECTIVE ACTIVATION OF ALPHA SUBTITUS RECEPTORS, AND FOR HORMONAL REPLACEMENT OR CONTRACEPTION THERAPY, AND," FARM COMPOSITION. The invention provides a substituted 16β steroid compound having formula 1 wherein the dotted ring is a fully saturated, fully aromatic ring or a saturated double bond <30> 5-10 ring; R2 is (C1 -C1 -C3) alkyl or (C1 -C2 -C3) alkenyl, and each of these groups may be substituted with one or more halogens; R 2 is C (C 1 -C 4) alkyl, (C 2 -C 4) alkenyl, or methylene, and each of these groups may be substituted with one or more halogens; R3 is methyl or ethyl; or a prodrug thereof, which can be used for selective estrogen receptor treatment.
priorityDate 2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 33.